Clinical Trial Update: Assess the Safety, Efficacy, and Pharmacokinetics of Immediate and Delayed Release Weekly Risedronate [Phase 2]

View source ↗

Summary

Phase 2 study assessing the safety, efficacy, and pharmacokinetics of immediate and delayed-release weekly risedronate in postmenopausal women; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• ATELVIA (RISENDRONATE SODIUM)
• Actonel (risedronate)

Snippet

Sponsor: Warner Chilcott | Conditions: Postmenopausal Women | Phase 2 | Status: COMPLETED | Results posted: 2012-01-13